Brigade Hotel Ventures · risk themes across the available quarters.
Bear-case history
Approximately ₹14 crore (10% of revenue) lost due to MICE cancellations in Q1, with 60% of impact on F&B and 40% on rooms. Management characterized this as postponed rather than cancelled events, but Q2-Q3 comparisons will be difficult given H1 FY26 was also impacted.
FDA share fell from 40% to 30%, directly impacting ADR since foreign travelers pay higher rates. Management noted ADR pressure but claimed it was offset by domestic demand. If international recovery lags, sustained ADR weakness could emerge.
Grand Hyatt Bangalore, originally slated for FY28, faces slight delay due to pending approvals. Management did not quantify the revised timeline but acknowledged execution risk on this flagship luxury asset.
Analyst questioned whether management can sustain RevPAR growth while balancing occupancy vs. rate optimization. Management acknowledged shortened booking windows require more agile pricing decisions, increasing execution risk.
The INR 3,600 crores capex plan is back-ended, with potential delays in construction and cost overruns.
A one-off property tax expense of INR 6 crores hit EBITDA; similar reassessments could occur at other properties.
Bangalore occupancy declined from 81% to 78% YoY, indicating potential market saturation or competitive pressure.
GST 2.0 reduced EBITDA margin by 1.6% due to input tax credit reversal on rooms below INR 7,500 ARR. Seven of nine hotels are below this threshold, though portfolio ARR is approaching INR 7,300.
One hotel's contract with Marriott ends December 2026. Management is negotiating renewal or potential upbranding, creating uncertainty.
Large capex of INR 3,600cr is back-ended, with peak debt-to-EBITDA expected at 4.5-5x in FY29-30. Execution delays or cost overruns could strain balance sheet.
Construction of Grand Hyatt Chennai is pending CRZ approval, which management expects by end of FY26. Any delay could push back the FY28 opening.